International
EFSA suspends assessment of CBD orders as a “novel food”
The evaluation of applications for submission of cannabidiol (CBD) as a novel food at the European Food Safety Agency (EFSA) is suspended, after a note published by the entity. At stake will be the lack of robustness in the documentation of submissions. EFSA scientists are unable to establish the safety of CBD as a novel food due to data gaps and uncertainties about the potential risks related to CBD ingestion.
Last week, the industry learned about an EFSA opinion, long awaited and requested by the European Commission (EC), within the scope of assessments regarding the safety of the use of CBD as a novel food. The report, entitled “Statement on the safety of cannabidiol as a novel food: data gaps and uncertainties”, was written by the EFSA expert panel on nutrition, novel foods and food allergens (NDA), which received 19 applications for CBD as a novel food, with more applications in the pipeline.
The Chairman of the NDA Panel, Prof. Dominique Turck said: “We have identified several hazards related to CBD ingestion and determined that the various data gaps on these health effects need to be corrected before these assessments can proceed. It is important to emphasize at this point that it has not been concluded that CBD is unsafe as a food.”
The agency claimed that there was insufficient data on the effects of CBD on people's liver, gastrointestinal tract, endocrine system, nervous system and psychological well-being. Animal studies show significant adverse effects mainly in relation to reproduction. It is important to determine whether these effects are also observed in humans.
The Panel identified several hazards related to CBD ingestion and pointed to deficiencies in experimental data in animals and humans.
The issues raised by EFSA regarding the data and uncertainties identified in the declaration must now be reviewed by applicants to provide the basis for the safety assessment of CBD as a novel food.
Industry reactions
The news of the suspension of evaluation requests caught some stakeholders by surprise, who recognize that the need for new assessments and tests with these products may arise from this report, in order to ensure that regulators are given the necessary safety guarantees. For now, the big change will be the need to include human trials in the toxicity and reproduction issues raised by the panel of experts, due to the fact that there have not been results with rodents satisfactory enough to assume that the consumption of CBD is safe.
If, on the one hand, some of the applicants reevaluate their projects and the costs associated with the redefinition of the tests, the EIHA - European Industrial Hemp Association, anticipating a similar situation and advanced to a more robust study that brought together more than 100 companies and with a view to providing the industry with solid and robust data on the use of CBD.
EFSA will provide a debriefing session for the various stakeholders and applicants
EFSA has received several requests for the use of cannabidiol (CBD) as a novel food. The large volume of requests and the statement issued regarding the risks of CBD, led EFSA to organize, for June 28, from 15 pm to 17 pm (Central European Time Zone), an information session regarding the data needs to proceed with the requests.
The event will take place online and registration is free, and must be held until the 17th of June at a web page made available for this purpose.
The information session aims to promote understanding of the NDA Panel statement on the uses of cannabidiol (CBD) as a novel food, focusing on data gaps identified in the scientific literature, provide guidance to candidates on how they can address data gaps identified, which mainly concern the potential effects of CBD on drug metabolism, liver, gastrointestinal tract, hormonal responses, nervous system and reproduction as well as answering questions from candidates and interested parties.
Infosessio-CBD-programme____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.
I can be contacted by email at joao.costa@cannareporter.eu
Thailand has found a solution where European countries still see a problem.
Reading Time: 13 minutes On my second trip to Thailand, I was once again pleasantly surprised. After visiting several...
The Royal Thai Embassy in Tokyo promotes "Adapting International Hemp to Japan's New Regulations"
Reading Time: 3 minutes The International Business Meeting “Adapting the International Market...” will take place tomorrow, November 13, 2025.
Portugal: Infarmed updates lists and removes licenses from two more medicinal cannabis companies.
Reading Time: 2 minutes. Infarmed has updated the public list of entities licensed for activities with medicinal cannabis in Portugal. The...
Portocanna strengthens its Hexacan portfolio with a new sublingual solution containing 20% THC.
Reading Time: 2 minutes. The Portuguese company Portocanna announced the launch of Hexacan® Hexa 01 Cannabis Oil Extract THC 20%,...
Cypress Hill confirmed for Rock in Rio Lisboa 2026
Reading Time: 2 minutes. The legendary American band Cypress Hill, whose hits "Insane in the Brain" and "Hits from the Bong"...
USA: Green Thumb Industries workers secure collective agreement after 45-day strike.
Reading Time: < 1 minute Workers at Green Thumb Industries, one of the largest multi-state cannabis companies in the United States...
Switzerland: Pacrim takes control of Medropharm and prepares for a new phase of expansion in medicinal cannabis.
Reading Time: 2 minutes. Pacrim has acquired two-thirds of the Swiss company Medropharm, thus gaining control of the company and its operations.
South Africa: Researchers discover rare phenolic compounds in cannabis leaves.
Reading Time: 4 minutes. Researchers at Stellenbosch University in South Africa have discovered that flavoalkaloids are produced in the leaves of the plant...
Covilhã – Dismantling of two cannabis greenhouses
Reading Time: < 1 minute The Castelo Branco Territorial Command, through the Criminal Investigation Unit (NIC) of Covilhã, in...
Tokyo will host the Japan International Hemp Expo on November 14th and 15th, 2025.
Reading Time: 4 minutes. For the first time since the legal reform, Japan opens its doors to the global hemp industry...
